The Modernization of Cosmetics Regulation Act is a touch ambiguous in a section concerning cosmetic product adulteration, which could pose legal questions for small manufacturers, says Angela Diesch, an attorney with Amin Wasserman Gurnani, LLP.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
More from United States
More from Conferences
• By
GSCF research shows that self-care already saves the Asia Pacific region more than $30bn a year in healthcare system costs. To realize higher gains, health literacy, Rx-to-OTC switch and digitalization need to be leveraged, according to the EU-ASEAN Business Council.
• By
APAC health agencies such as WHO and Thailand's FDA are on board with the self-care agenda, and see it as crucial to achieving universal health coverage.
• By
Single-use packaging producers should heed the 1 October deadline in Colorado’s EPR law for paper and packaging to register with Circular Action Alliance lest they face enforcement action, said an advisor for that organization, which is leading the program’s administration, at IBA’s Cosmetics Convergence Fall 2024 Virtual Symposium.